细菌疫苗创新与应用

Innovation and Application of Bacterial Vaccines

关键词:  细菌疫苗  技术创新  产业应用  质量控制

Key words:  bacterial vaccine  technological innovation  industrial application  quality control

摘要:

细菌性疾病是全球公共卫生的重大挑战，在抗菌药物耐药性危机不断加剧的背景下，疫苗的主动预防战略价值愈发突出。依托免疫学、合成化学、结构生物学、合成生物学等多学科交叉技术的突破性进展，细菌疫苗研发迈入精准化、多元化发展新阶段，传统疫苗迭代优化持续推进，新型疫苗技术研发与应用不断提速，针对难治性致病菌的防控技术已然成为本领域核心攻关方向。为系统梳理展示该领域前沿研究成果，构建“产学研审评”深度融合的学术交流平台，本期特推出“细菌疫苗创新与应用”专栏。专栏聚焦“疫苗设计源头创新与技术平台”、“产业化关键技术与产品升级”、“质量控制体系与法规科学”3个维度，广泛征集高质量学术成果，旨在汇聚领域内前沿技术、创新方法与实践经验，为细菌疫苗原始创新能力提升与科研成果产业转化提供参考和启示。

Abstract:

Bacterial diseases pose a major challenge to global public health. Against the backdrop of the escalating crisis of antimicrobial resistance, the strategic value of proactive prevention via vaccines has become increasingly prominent. Fueled by groundbreaking advances in interdisciplinary technologies spanning immunology, synthetic chemistry, structural biology, synthetic biology and beyond, the research and development (R&D) of bacterial vaccines has entered a new era of precise and diversified development, including steady iterative optimization of conventional vaccines and accelerated R&D and application of novel vaccine technologies. Prevention and control technologies targeting intractable pathogenic bacteria have become the core research priorities in this field. To systematically review and showcase cutting-edge research achievements in this discipline and build an academic exchange platform featuring in-depth integration of industry, academia, research and regulatory evaluation, this issue features a special column titled “Innovation and Application of Bacterial Vaccines”. This special column focuses on three research dimensions including “original innovation in vaccine design and technical platforms”, “industrialization key technologies and product upgrading”, as well as “quality control systems and regulatory science”. It broadly calls for high-quality academic outputs, aiming to gather state-of-the-art technologies, innovative methodologies and practical experience within the field, so as to provide references and insights for enhancing the capacity of original innovation in bacterial vaccines and facilitating the industrial transformation of scientific research findings.